Home › Crohn's Disease › Georgia › Macon
Crohn's Disease clinical trials in Macon, GA
5 studies for Crohn's Disease are looking for participants at sites in and around Macon (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RecruitingPhase 3
- Gastroenterology Associates of Central Georgia ( Site 5048), Macon
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- Gastroenterology Associates of Central Georgia /ID# 280464, Macon
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RecruitingPhase 2
- Gastroenterology Associates of Central Georgia /ID# 265547, Macon
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Gastroenterology Associates of Central GA, Macon
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 2/3
- Gastroenterolgy Associates of Central GA, Macon
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Orlando, FL17 studies
- Houston, TX17 studies
- Atlanta, GA17 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- San Antonio, TX15 studies
- Los Angeles, CA15 studies
Other studies in Macon
- Disorders of Excessive Somnolence5 studies
- Narcolepsy4 studies
- Sleep Disorders4 studies
- Atopic Dermatitis (Eczema)3 studies
- Type 2 Diabetes3 studies
- Non-Small Cell Lung Cancer3 studies
- Cardiovascular Disease3 studies
- Fatigue3 studies
- Ulcerative Colitis3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.